Brief: Sanofi India Recalls One Batch Of Lasix® As Directed By Kerala Drug Control Department
Nov 13 (Reuters) - Sanofi India Ltd SANO.NS :
* SAYS HAVE RECALLED STOCKS OF ONE BATCH OF LASIX® FROM
MARKET
BASED ON DIRECTIVE ISSUED BY KERALA DRUG CONTROL DEPARTMENT
* SAYS RECALL WILL NOT HAVE ANY MATERIAL IMPACT ON FINANCIAL
STATEMENTS
* SAYS CONTROL SAMPLES ARE IN LINE WITH DEFINED QUALITY
PARAMETERS AND DO NOT SHOW ANY DEVIATION
Source text: http://bit.ly/2B4m1Yj
Further company coverage: SANO.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sanofi India
See all newsSanofi India gains as quarterly profit doubles on strong diabetes business performance
Brief: Sanofi India Sept-Quarter Profit 1.17 Billion Rupees
Brief: Sanofi India Gets Tax Notice Worth 164 Million Rupees
Brief: Sanofi India Says Supreme Court Of India Has Dismissed Co's Petition Seeking Quashing Of Criminal Proceedings
Brief: Sanofi India Says Tax Demand Of 7.3 Million Rupees Vacated For AY 2019-20